Projected future investments among life sciences companies 2018
This statistic depicts the percentage of biopharma and medtech firms that expect to invest in select activities, according to a survey conducted during summer 2018. According to the survey, 65 percent of respondents said that their firm was likely/very likely to invest in research and development.
